Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2003
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003US20030087264 Detection of regulatory response to pulsatile electromagnetic stimulus; obtain tissue sample, insert probe, apply pulsatile stimulus, detect gene expression, classify genes which are expresed
05/08/2003US20030086989 Morinda citrifolia enhanced lip treatment
05/08/2003US20030086980 Method for the suppression of visceral pain by regulating T type calcium channel
05/08/2003US20030086938 Effecting presentation to the animal's immune system of an immunogenically effective amount of at least one analogue of autologous beta amyloid (A beta ) protein or autologous amyloid precursor
05/08/2003US20030086901 Combination therapies using vitamin B12 and interferon for treatment of viral, proliferative and inflammatory diseases
05/08/2003CA2756610A1 Methods for producing proteins having n-linked glycans comprising (sialyl-) lewis x or lacdinac structures
05/08/2003CA2466824A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003CA2466424A1 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
05/08/2003CA2465653A1 Method for inducing differentiation of mesodermal stem cells, es cells, or immortalized mesodermal stem cells into neural cells
05/08/2003CA2465438A1 Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells
05/08/2003CA2465350A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003CA2465344A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003CA2465316A1 Hydroxy substituted amides for the treatment of alzheimer's disease
05/08/2003CA2465314A1 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
05/08/2003CA2465306A1 Substituted 1h-quinolin-2-one compounds
05/08/2003CA2465236A1 Substituted indoles, method for production and use thereof for the inhibition of pain
05/08/2003CA2465188A1 Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor
05/08/2003CA2465061A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
05/08/2003CA2465040A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003CA2464997A1 Silicon compounds
05/08/2003CA2464945A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
05/08/2003CA2464944A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003CA2464934A1 Pyrimido [4,5-b] indole derivatives
05/08/2003CA2464888A1 Pyridine derivatives as nmda-receptor subtype blockers
05/08/2003CA2464887A1 Methods and compositions for treating parkinson's disease
05/08/2003CA2464727A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/08/2003CA2464656A1 Spray drying methods and compositions thereof
05/08/2003CA2464353A1 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003CA2464342A1 Therapeutic isoquinoline compounds
05/08/2003CA2464194A1 N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists
05/08/2003CA2464191A1 Substituted benzo[b]azepin-2-one compounds
05/08/2003CA2463823A1 Aminobenzamide derivatives as glycogen synthase kinase 3.beta. inhibitors
05/08/2003CA2463822A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003CA2463821A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003CA2463770A1 Compounds useful as reversible inhibitors of cysteine proteases
05/08/2003CA2463580A1 Polymer conjugates of protein kinase c inhibitors
05/08/2003CA2463441A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003CA2463158A1 Depot formulations of iloperidone and a star polymer
05/08/2003CA2462660A1 Nucleic acid-associated proteins
05/08/2003CA2462525A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003CA2462206A1 Substituted thioacetamides
05/08/2003CA2460118A1 Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome
05/07/2003EP1308513A1 Use of polypeptide
05/07/2003EP1308509A1 Novel physiologically active peptide and use thereof
05/07/2003EP1308447A1 Purine derivatives having antiproliferative properties and biological uses thereof
05/07/2003EP1308446A1 5-(alkylidene-cycloalkyl)- and 5-(alkylidene-heterocyclyl)-pyrazoles
05/07/2003EP1308445A1 5-heteroatom-substituted pyrazoles
05/07/2003EP1308441A1 2-aminopyridine compounds and use thereof as drugs
05/07/2003EP1308440A1 Piperidine derivatives and drugs containing these derivatives as the active ingredient
05/07/2003EP1308438A1 3-substituted urea derivatives and medicinal use thereof
05/07/2003EP1308162A1 Pernasal preparation
05/07/2003EP1308161A1 5-N-heterocyclyl-1-(4-sulfonyl-phenyl)-1H-pyrazole derivatives with cyclooxygenase 2 (COX-2) inhibiting activity for the treatment of inflammatory diseases
05/07/2003EP1308158A1 Sulfonylaryl- and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/07/2003EP1307588A2 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE AND USES THEREOF
05/07/2003EP1307567A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
05/07/2003EP1307566A2 Mitogen activated kinase
05/07/2003EP1307559A2 Slit-like protein obtained from a cdna library from hs-5 stromal cell line
05/07/2003EP1307554A2 C3b/c4b complement receptor-like molecules and uses thereof
05/07/2003EP1307552A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
05/07/2003EP1307463A1 Pyrrolo 2,1-b]-[1,3]benzothiazepines and their use for the preparation of medicaments with antipsychotic activity
05/07/2003EP1307456A1 Imidazo-pyrazine derivatives as ligands for gaba receptors
05/07/2003EP1307453A2 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers
05/07/2003EP1307449A1 1,4-dihydropyridines as bradykinin antagonists
05/07/2003EP1307448A1 Tartrate salts of thiazolidinedione derivative
05/07/2003EP1307447A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
05/07/2003EP1307430A1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
05/07/2003EP1307425A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides
05/07/2003EP1307245A1 Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter
05/07/2003EP1307233A2 Therapeutic polyanhydride compounds for drug delivery
05/07/2003EP1307229A1 Combination preparation with an er-beta selective estrogen and a serm or antiestrogen
05/07/2003EP1307225A2 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
05/07/2003EP1307219A2 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof
05/07/2003EP1307205A2 Use of 7alpha-hydroxy-estradiol, 7alpha-hydroxy-dehydroepiandrosterone and 7alpha-hydroxy-pregnenolone derivatives for treating acute cellular degeneration
05/07/2003EP1307201A2 Selective pde 2 inhibitors, used as medicaments for improving cognition
05/07/2003EP1307194A1 Fentanyl composition for nasal administration
05/07/2003EP1307193A1 Agonists of follicle stimulating hormone activity
05/07/2003EP1307192A1 New use of angiotensin ii antagonists
05/07/2003EP1307182A2 Pharmaceutical composition for transdermal delivery of befloxatone
05/07/2003EP1216043B1 Retard form containing alpha-lipoic acid (derivatives)
05/07/2003EP1204658B1 Benzofurylpiperazine serotonin agonists
05/07/2003EP1200106B1 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement
05/07/2003EP1183035A4 Bone marrow transplantation for treatment of stroke
05/07/2003EP1147110B1 Pyrazino(aza)indole derivatives
05/07/2003EP1140825B1 Melatonin derivatives and medicine containing same
05/07/2003EP1131326B1 Phospholipid derivatives of non-steroidal anti-inflammatory drugs
05/07/2003EP1112251B1 Azetidine derivatives, preparation and medicines containing them
05/07/2003EP1107775B1 Composition containing pyrrolizidine-alkaloid-free petasites
05/07/2003EP1097698B1 Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain
05/07/2003EP1090004B1 A substituted triazolo-pyridazine derivative, pharmaceutical compositions made therefrom
05/07/2003EP1054863B1 2-aminoquinoline derivatives having d4-agonistic activity
05/07/2003EP1045822B1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments
05/07/2003EP1033987B1 Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters
05/07/2003EP1023051B1 Oral morphine multiparticulate formulation
05/07/2003EP1001956B1 2,3-benzodiazepine derivatives
05/07/2003EP0966287B1 Oxacarbazepine film-coated tablets
05/07/2003EP0900076B1 Transdermal device
05/07/2003EP0893997B1 Paroxetine in treatment of depression
05/07/2003EP0874621B1 [3'-DESOXY-3-OXO-MeBmT]1-[Val]2-CICLOSPORIN-CONTAINING EMULSION PHARMACEUTICAL COMPOSITIONS
05/07/2003EP0869791B1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
1 ... 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 ... 1833